PUMA BIOTECHNOLOGY, INC. Proceeds from Related Party Debt
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Proceeds from Related Party Debt of $150.00 thousand for the 48-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2014-11-10
- PUMA BIOTECHNOLOGY, INC. proceeds from related party debt for the quarter ending 2014-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. proceeds from related party debt for the quarter ending 2014-03-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. proceeds from related party debt for the quarter ending 2013-12-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. proceeds from related party debt for the quarter ending 2013-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. proceeds from related party debt for fiscal 2011 was $150.00K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month | Proceeds from Related Party Debt 16 month | Proceeds from Related Party Debt 18 month | Proceeds from Related Party Debt 21 month | Proceeds from Related Party Debt 25 month | Proceeds from Related Party Debt 27 month | Proceeds from Related Party Debt 30 month | Proceeds from Related Party Debt 33 month | Proceeds from Related Party Debt 36 month | Proceeds from Related Party Debt 39 month | Proceeds from Related Party Debt 42 month | Proceeds from Related Party Debt 45 month | Proceeds from Related Party Debt 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 48 month − 10-Q 45 month · filed 2014-11-10 | $150.00K 10-Q · filed 2014-11-10 | ||||||||||||||
| 2014-06-30 | $150.00K 10-Q · filed 2014-08-11 | |||||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 42 month − 10-K 39 month · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2014-05-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-12 | $0.00 derived: sum of 4 quarters · filed 2014-05-12 | $150.00K 10-Q · filed 2014-05-12 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 39 month − 10-Q 36 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $0.00 derived: sum of 3 quarters · filed 2014-03-03 | $0.00 derived: sum of 4 quarters · filed 2014-03-03 | $150.00K 10-K · filed 2014-03-03 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 36 month − 10-Q 33 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2013-11-12 | $150.00K 10-Q · filed 2013-11-12 | ||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 33 month − 10-Q 30 month · filed 2013-08-06 | $0.00 derived: sum of 2 quarters · filed 2013-08-06 | $150.00K 10-Q · filed 2013-08-06 | |||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 30 month − 10-K 27 month · filed 2013-05-09 | $150.00K 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | $150.00K 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $150.00K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 21 month − 10-Q 18 month · filed 2012-08-14 | $150.00K 10-Q · filed 2012-08-14 | ||||||||||||||
| 2012-03-31 | $150.00K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $150.00K 10-K · filed 2014-03-03 | $150.00K 10-K · filed 2012-03-29 | |||||||||||||
| 2011-09-30 | $150.00K 10-Q · filed 2012-11-14 | $150.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |